Company
United StatesPublic company, NASDAQ: INSMInsmed Incorporated (NASDAQ: INSM), Bridgewater, NJ – FDA Inspections
Inspection records and compliance data for Insmed Incorporated in Bridgewater, New Jersey. 3 FDA inspections on record, 1 Form 483, last inspected April 03, 2025. Publicly traded as NASDAQ: INSM.
Company Profile
This profile covers Insmed Incorporated based in Bridgewater, New Jersey, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 1
- NAI
- 2
- Form 483s
- 1
- Warning letters
- 0
First inspected January 21, 2009. Last inspected April 3, 2025.
Most cited issue areas
- Failure to develop written procedures1 inspection
- General responsibilities of sponsors1 inspection
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| April 3, 2025 | NAI | Human Drugs · Bioresearch Monitoring: Human Drugs | 1265807 |
| August 3, 2021 | VAI | Human Drugs · Bioresearch Monitoring | 1147825 |
| January 21, 2009 | NAI | Human Drugs · Bioresearch Monitoring | 556842 |
FDA documents
Form 483s (1)
People (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Insmed Incorporated
Stock ticker
INSM
Exchange
NASDAQ
Share price
$118.07
Market cap
$25.9B
Price as of
November 13, 2026
FEI Number
3001236995
Address
700 Us Highway 202/206, Bridgewater, New Jersey 08807, United States
Country
United States
ID: 2b1442ae-b800-4f95-90a5-f0891d7adc79